CATALYS PACIFIC
Catalys Pacific is an independent venture capital firm focusing on early-stage investments in life sciences. Founded in 2019, the firm's mission is to focus on providing healthcare solutions for patients worldwide through the creation of and investment in bioventure companies. Catalys Pacific is led by a global team versed in working closely with its partners in academia, biotech, venture capital and the pharmaceutical industry in Japan and worldwide. The firm maintains offices in Tokyo and Kanagawa (Shonan Health Innovation Park), Japan and in Seattle, Washington.
CATALYS PACIFIC
Social Links:
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2019-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-08 | Mineralys Therapeutics | Catalys Pacific investment in Series B - Mineralys Therapeutics | 118 M USD |
| 2022-03-28 | Aculys Pharma | Catalys Pacific investment in Series B - Aculys Pharma | 2.8 B JPY |
| 2021-10-28 | Aculys Pharma | Catalys Pacific investment in Series A - Aculys Pharma | 6.8 B JPY |
| 2021-09-08 | HilleVax | Catalys Pacific investment in Venture Round - HilleVax | 135 M USD |
| 2021-06-22 | Pathalys Pharma | Catalys Pacific investment in Seed Round - Pathalys Pharma | 11 M USD |
| 2021-04-06 | Mineralys Therapeutics | Catalys Pacific investment in Seed Round - Mineralys Therapeutics | 4 M USD |
| 2021-04-06 | Mineralys Therapeutics | Catalys Pacific investment in Series A - Mineralys Therapeutics | 40 M USD |
| 2020-07-16 | Exalys Therapeutics | Catalys Pacific investment in Series A - Exalys Therapeutics | 15 M USD |
| 2019-05-15 | Phathom Pharmaceuticals | Catalys Pacific investment in Private Equity Round - Phathom Pharmaceuticals | 90 M USD |